Target's rollback on diversity, equity and inclusion initiatives is raising questions about the retail giant's philanthropic commitment to

Trump continues his crackdown on illegal immigration and takes executive action on federal aid and DEI initiatives.

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM Evidence. The full article, entitled, "Larsucosterol for the Treatment of Alcohol-Associated Hepatitis,

The FDA says about 2,756 jars of First Aid Beauty Ultra Repair Cream Coconut Vanilla are being recalled due to a deviation from Current Good Manufacturing Practice regulations, which regulates quality, safety, consistency and packaging in drug or cosmetic products.

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.

SeaStar Medical plans to conduct an interim analysis at the trial’s 90-day primary endpoint with the first 100 subjects. Given the current pace of enrollment, the company anticipates a Data Safety Monitoring Board (DSMB) recommendation on the interim results by mid-2025.

PORTLAND, IN, UNITED STATES, January 28, 2025 /EINPresswire / -- The RNA based therapeutics has been explored as a promising treatment option for the diseases which are difficult to treat. Development of this therapeutics is based on promising technologies such as RNA interference technology (RNAi),

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions as reported in a recent SEC filing. On January 27, Benkowitz sold shares amounting to approximately $3.

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial & Business Operations.

Minister for Defence Pio Tikoduadua confirmed that authorities are aware of several Fijians living in the U.S. who have been involved in drug-related crimes and are now facing deportation. He also noted that individuals from other Pacific Island nations are included in these discussions.